Virtus ETF Advisers’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-8,153
Closed -$63K 718
2024
Q4
$63K Buy
8,153
+1,110
+16% +$10.4K 0.03% 435
2024
Q3
$73.9K Buy
7,043
+122
+2% +$1.49K 0.03% 420
2024
Q2
$81K Buy
6,921
+2,762
+66% +$43K 0.04% 402
2024
Q1
$87.6K Sell
4,159
-288
-6% -$5.13K 0.05% 384
2023
Q4
$79.8K Sell
4,447
-578
-12% -$10.2K 0.05% 417
2023
Q3
$82.7K Sell
5,025
-498
-9% -$9.03K 0.05% 356
2023
Q2
$110K Buy
5,523
+1,266
+30% +$24.4K 0.07% 345
2023
Q1
$80.5K Sell
4,257
-1,636
-28% -$36.2K 0.04% 384
2022
Q4
$134K Buy
5,893
+645
+12% +$14.6K 0.07% 384
2022
Q3
$139K Buy
5,248
+39
+0.7% +$1.16K 0.06% 364
2022
Q2
$129K Buy
5,209
+379
+8% +$9.47K 0.05% 356
2022
Q1
$160K Sell
4,830
-282
-6% -$7.83K 0.07% 217
2021
Q4
$167K Sell
5,112
-548
-10% -$18.7K 0.06% 300
2021
Q3
$237K Sell
5,660
-302
-5% -$10.9K 0.1% 225
2021
Q2
$232K Sell
5,962
-1,516
-20% -$54.2K 0.1% 238
2021
Q1
$255K Buy
7,478
+139
+2% +$5.93K 0.11% 284
2020
Q4
$333K Sell
7,339
-1,420
-16% -$49.6K 0.14% 184
2020
Q3
$241K Sell
8,759
-1,193
-12% -$38.9K 0.13% 274
2020
Q2
$367K Buy
9,952
+1,716
+21% +$64K 0.17% 243
2020
Q1
$267K Sell
8,236
-1,200
-13% -$50K 0.11% 244
2019
Q4
$387K Buy
9,436
+4,204
+80% +$166K 0.06% 270
2019
Q3
$186K Sell
5,232
-292
-5% -$11.8K 0.04% 260
2019
Q2
$284K Sell
5,524
-317
-5% -$15.8K 0.06% 240
2019
Q1
$335K Sell
5,841
-681
-10% -$33.7K 0.71% 49
2018
Q4
$274K Sell
6,522
-1,930
-23% -$113K 0.05% 140
2018
Q3
$638K Sell
8,452
-6,040
-42% -$435K 0.07% 89
2018
Q2
$1.04M Sell
14,492
-12,068
-45% -$576K 0.92% 8
2018
Q1
$793K Buy
26,560
+14,309
+117% +$416K 0.69% 74
2017
Q4
$407K Sell
12,251
-5,020
-29% -$151K 0.51% 50
2017
Q3
$569K Buy
17,271
+1,580
+10% +$35.6K 0.08% 82
2017
Q2
$310K Buy
+15,691
New +$304K 0.05% 116

Other funds holding RGNX